In contrast, increased expression of MRCKβ showed no obvious effect on breast cancer survival and cancers with high expression of MRCKβ were strongly depleted in the Basal subset (Supplementary Figure S1). This evidence concerns the gene CDC42BPB and breast carcinoma.